Summary:
- This article discusses the development of a new malaria vaccine called R21/Matrix-M, which has shown promising results in clinical trials.
- The vaccine was developed by researchers at the University of Oxford and has been found to be 77% effective in preventing malaria in young children in Burkina Faso.
- This vaccine could be a significant breakthrough in the fight against malaria, a disease that affects millions of people, especially in sub-Saharan Africa.